Reproducibility of high-sensitivity C-reactive protein as an inflammatory component of metabolic syndrome in Japanese

Circulation Journal

Volumn 74, Issue 7, 2010, Pages 1488-1493

  Oda, Eiji ^a   Kawai, Ryu ^a  

^a Tachikawa Medical Center   (Japan)

Author keywords

High sensitivity c reactive protein; Inflammation; Japanese; Metabolic syndrome

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; DIAGNOSTIC VALUE; FEMALE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; METABOLIC SYNDROME X; PROTEIN BLOOD LEVEL; REFERENCE VALUE; REPRODUCIBILITY; SENSITIVITY ANALYSIS; SEX DIFFERENCE; ASIAN CONTINENTAL ANCESTRY GROUP; INFLAMMATION; MIDDLE AGED; PATHOLOGY; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; STANDARDS;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; C-REACTIVE PROTEIN; FEMALE; HUMANS; INFLAMMATION; MALE; MASS SCREENING; METABOLIC SYNDROME X; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; ROC CURVE;

EID: 77954489747     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0156     Document Type: Article

References (30)

1. Ruderman NB, Schneider SH, Berchtold P. The metabolically-obese, normal-weight individual. Am J Clin Nutr 1981; 34: 1617-1621.
2. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
3. Festa A, D'Agostino R, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 102: 42-47.
4. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: A statement for health care professionals: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.
5. Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome: A new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-480.
6. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645.
7. Oda E. The metabolic syndrome as a concept of adipose tissue disease. Hypertens Res 2008; 31: 1283-1291.
8. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α: Direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91.
9. Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E, et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 2005; 46: 2347-2355.
10. Oda E, Kawai R. Comparison between high-sensitivity C-reactive protein (hs-CRP) and white blood cell count (WBC) as an inflammatory component of metabolic syndrome in Japanese. Intern Med 2009; 49: 117-124.
11. Doi Y, Wakugawa Y, Kiyohara Y, Yonemoto K, Kubo M, Iwase M, et al. Elevated C-reactive protein is a predictor of diabetes in a general Japanese population: The Hisayama study. Diabetes Care 2005; 28: 2497-2500.
12. Ridker PM, Wilson PWF, Grandy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 2004; 109: 2818-2825.
13. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M, et al. Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511.
14. Nakanishi N, Shiraishi T, Wada M. C-reactive protein concentration is more strongly related to metabolic syndrome in women than in men: The Minoh study. Circ J 2005; 69: 386-391.
15. Saijo Y, Yoshioka E, Fukui T, Kawaharada M, Kishii R. Metabolic syndrome, C-reactive protein and increased arterial stiffness in Japanese subjects. Hypertes Res 2006; 29: 589-596.
16. Matsushita K, Yatsuya H, Tamakoshi K, Yang PO, Otsuka R, Wada K, et al. High-sensitivity C-reactive protein is quite low in Japanese men at high coronary risk. Circ J 2007; 71: 820-825.
17. Oda E, Kawai R. Very low levels of high-sensitivity C-reactive protein are not bimodaly distributed but significantly related with other metabolic risk factors in Japanese. Intern Med 2009; 48: 953-958.
18. Oda E, Kawai R. Tentative cut-off point of high-sensitivity C-reac-tive protein for a component of metabolic syndrome in Japanese. Circ J 2009; 73: 755-759.
19. Koenig W, Sund M, Frohlich M, Lowel H, Hutchinson WL, Pepys MB. Refinement of the association of serum C-reactive protein concentration and coronary heart disease risk by correction for within-subject variation over time: The MONICA Augsburg Studies, 1984 and 1987. Am J Epidemiol 2003; 158: 357-364.
20. Takeno M, Yasuda S, Otsuka Y, Morii I, Kawamura A, Yano K, et al. Impact of metabolic syndrome on the long-term survival of patients with acute myocardial infarction: Potential association with C-reactive protein. Circ J 2008; 72: 415-419.
21. Matsuo Y, Hashizume T, Shioji S, Akasaka T. Metabolic syndrome is strongly associated with chronic subclinical inflammation in patients achieving optimal low-density lipoprotein-cholesterol levels in secondary prevention of cardiovascular disease. Circ J 2008; 72: 2046-2050.
22. Ridker PM, Rifai N, Pfeffer MA, Braunwald SF. Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation 1999; 100: 230-235.
23. Ockene IS, Matthews CE, Rifai N, Ridker PM, Reed G, Stanek E. Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem 2001; 47: 444-450.
24. Nasermoaddeli A, Sekine M, Kagamimori S. Intra-individual variability of high-sensitivity C-reactive protein: Age-related variation over time in Japanese subjects. Circ J 2006; 70: 559-563.
25. Kayaba K, Ishikawa S, Gotoh T, Naga N, Kajii E, Nakamura Y, et al. Five-year intra-individual variability in C-reactive protein levels in a Japanese population-based study: The Jichi Medical School Cohort Study at Yamato, 1993-1998. Jpn Circ J 2000; 64: 303-308.
26. Yamada S, Gotoh T, Nakashima Y, Kayaba K, Ishikawa S, Nago N, et al. Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population. Am J Epidemiol 2001; 153: 1183-1190.
27. Ridker PM, Cook N. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham risk scores. Circulation 2004; 109: 1955-1959.
28. Pou KM, Massaro JM, Hoffmann U, Vasan RS, Maurovich-Horvat P, Larson MG, et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: The Framingham Heart Study. Circulation 2007; 116: 1234-1241.
29. Rutter MK, Wilson PWF, Sullivan LM, CS Fox, D'Agostino RB, Meigs JB. Use of alternative thresholds defining insulin resistance to predict incident type 2 diabetes mellitus and cardiovascular disease. Circulation 2008; 117: 1003-1009.
30. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: A comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005; 111: 1448-1454.